By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



275 Middlefield Road
Suite 150
Menlo Park  California   94025  U.S.A.
Phone: 650-461-4600 Fax: n/a



Company News
Dermira (DERM) Release: Second CIMZIA (Certolizumab Pegol) Phase III Trial Meets Co-Primary Efficacy Endpoints In Patients With Moderate-To-Severe Chronic Plaque Psoriasis 12/8/2016 7:58:48 AM
Dermira (DERM) Presents Data From DRM01 Phase IIb Clinical Program At Annual Meeting For Dermatologists 10/21/2016 8:04:35 AM
Dermira (DERM) To Present Data From DRM01 And DRM04 Clinical Programs At Fall Clinical Dermatology Conference 10/13/2016 8:35:23 AM
Bay Area Dermira (DERM)'s CImzia Meets Co-Primary Endpoints in Key Phase III Study 10/3/2016 6:43:19 AM
Dermira (DERM) To Present Data From DRM04 Phase III Clinical Trials At Late-Breaking News Session At European Academy Of Dermatology And Venereology Congress 9/28/2016 7:38:20 AM
Dermira (DERM) Licenses DRM04 To Maruho For Hyperhidrosis In Japan 9/21/2016 10:50:10 AM
Bay Area's Dermira (DERM) Snags Deal to License Rights to Three of Takeda (TKPYY)'s Early-Stage Programs 9/12/2016 6:27:19 AM
Dermira (DERM) Reports Second Quarter 2016 Financial Results And Provides Corporate Update 8/9/2016 11:03:25 AM
Dermira (DERM) Jumps as Excessive Armpit Sweating Drug Succeeds in Late-Stage Studies 6/2/2016 6:13:06 AM
Dermira Completes Patient Enrollment For Second CIMZIA (Certolizumab Pegol) Phase III Clinical Trial In Psoriasis Program 11/19/2015 7:54:18 AM